跳转至内容
Merck
CN
  • New oligodendrocytes exhibit more abundant and accurate myelin regeneration than those that survive demyelination.

New oligodendrocytes exhibit more abundant and accurate myelin regeneration than those that survive demyelination.

Nature neuroscience (2022-02-16)
Sarah A Neely, Jill M Williamson, Anna Klingseisen, Lida Zoupi, Jason J Early, Anna Williams, David A Lyons
摘要

Oligodendrocytes that survive demyelination can remyelinate, including in multiple sclerosis (MS), but how they do so is unclear. In this study, using zebrafish, we found that surviving oligodendrocytes make few new sheaths and frequently mistarget new myelin to neuronal cell bodies, a pathology we also found in MS. In contrast, oligodendrocytes generated after demyelination make abundant and correctly targeted sheaths, indicating that they likely also have a better regenerative potential in MS.

材料
货号
品牌
产品描述

Sigma-Aldrich
Monoclonal Anti-CNP antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL2887, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-Myelin Proteolipid Protein Antibody, CT, clone PLPC1, clone PLPC1, Chemicon®, from mouse